RESEARCH PAPER
Figure from article: Multifactorial influence of...
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
People over 70 years of age have an especially high rate of morbidity through circulatory system diseases. One of the factors increasing cardiovasular risk (CV) is diabetes. Therefore, CV risk should be assessed to limit morbidity in older age and effectively reduce risk factors. The aim of the study is to assess the impact of type 2 diabetes mellitus (T2DM) on cardiovascular risk in people aged 70–89 years, based on the SCORE2-OP scale, taking into account other risk factors.

Material and methods:
The study was conducted among 514 people aged 70–89 with diabetes (T2DM(+); n=148) and without (T2DM(-); n=366). The appropriate SCORE2 – OP algorithm was used to assess CV risk. The created regression model indicated factors significantly affecting CV risk in this group of respondents.

Results:
The mean CV risk is significantly increased in the T2DM(+) group by 2.7% compared with the non-DM group – T2DM(-) (p=0.010). Intergroup analyses confirmed a significantly higher CV risk in single individuals (31.2±12.7) compared to married individuals (25.6±10.2), at the threshold of statistical significance. The model fit (0.91) indicated that age (1.0), smoking (1.0), systolic blood pressure (0.99), non-HDL cholesterol (0.65) and HR (0.52) increased CV risk.

Conclusions:
Non-modifiable risk factors such as age increase CV risk and their impact cannot be significantly reduced, but modifying factors such as non-HDL, HR, systolic blood pressure or smoking can significantly reduce CV risk.
REFERENCES (25)
1.
Krawczyk-Suszek M, Wyczarska-Dziki K, Zams B, et al. Multifactorial influence of type 2 diabetes on cardiovascular risk assessed by PolSCORE, SCORE2 in the age group 40–69 years. Ann Agric Environ Med. 2025; https://doi.org/10.26444/aaem/....
 
2.
Krawczyk-Suszek M, Gaweł A, Kleinrok A. Correlation of gender with health related-quality of life of patients in 13 groups of disease in Poland. Sci Rep. 2025;15(1):15277.
 
3.
Krawczyk-Suszek M, Gaweł A, Kleinrok A. Ranking of diseases affecting the health-related quality of life of patients in Poland – a cross-sectional study. Arch Med Sci. 2024;20(5):1567–1578.
 
4.
Wu TW, Chou CL, Cheng CF, et al. Prevalences of diabetes mellitus and carotid atherosclerosis and their relationships in middle-aged adults and elders: a community-based study. J Formos Med Assoc. 2022;121(6):1133–40.
 
5.
Marx N, Federici M, Schütt K, et al. 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44(39):4043–140.
 
6.
Ribeiro ASF, Zerolo BE, Lopez-Espuela F, et al. Cardiac System during the Aging Process. Aging Dis. 2023;14(4):1105–1122.
 
7.
Ageing and Health. WHO. https://www.who.int/news-room/... (access: 2025.07.22).
 
8.
Thiriet M. Cardiovascular Risk Factors and Markers. Vasculopathies. 2019;8:91–198.
 
9.
Abrignani MG, Lucà F, Abrignani V, et al. A Look at Primary and Secondary Prevention in the Elderly: The Two Sides of the Same Coin. J Clin Med. 2024;13(15):4350.
 
10.
Hageman S, Pennells L, Ojeda F, et al. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439–54.
 
11.
WMA Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. WMA. https://www.wma.net/what-we-do... (access: 2025.07.22).
 
12.
de Vries TI, Cooney MT, Selmer RM, et al. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455–67.
 
13.
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–104.
 
14.
Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(12):1925–66.
 
15.
Hanlon P, Butterly E, Wei L, et al. Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes. JAMA. 2025;333(12):1062.
 
16.
Castan-Laurell I, El Boustany R, Pereira O, et al. Plasma Apelin and Risk of Type 2 Diabetes in a Cohort From the Community. Diabetes Care. 2020;43(2):e15–6.
 
17.
Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2015;3(2):105–13.
 
18.
Berg FH, Lassen MCH, Vaduganathan M, et al. Cardiovascular Hospitalizations Among Older Adults in the US and Denmark. JAMA Cardiol. 2025;10(4):351.
 
19.
Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40.
 
20.
Cooney MT, Selmer R, Lindman A, et al. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol. 2016;23(10):1093–103.
 
21.
Araszkiewicz A, Bandurska-Stankiewicz E, Borys S, et al. Standards of Care in Diabetes. The position of Diabetes Poland – 2024. Current Topics in Diabetes. 2024;3(3–4):1–348.
 
22.
Ciumărnean L, Milaciu MV, Negrean V, et al. Cardiovascular Risk Factors and Physical Activity for the Prevention of Cardiovascular Diseases in the Elderly. Int J Environ Res Public Health. 2021;19(1):207.
 
23.
Kunutsor SK, Laukkanen JA. Physical activity, exercise and adverse cardiovascular outcomes in individuals with pre-existing cardiovascular disease: a narrative review. Expert Rev Cardiovasc Ther. 2024;22(1–3):91–101.
 
24.
Isath A, Koziol KJ, Martinez MW, et al. Exercise and cardiovascular health: A state-of-the-art review. Prog Cardiovasc Dis. 2023;79:44–52.
 
25.
Tucker WJ, Fegers-Wustrow I, Halle M, et al. Exercise for Primary and Secondary Prevention of Cardiovascular Disease. J Am Coll Cardiol. 2022;80(11):1091–106.
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top